New pill for scarred lungs shows promise in early trial
Disease control
Completed
This study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring and breathing difficulty. The main goal was to check safety and tolerability over 12 weeks, comparing the drug to a placebo. Re…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 17, 2026 02:24 UTC